WHO非洲区域部署SARS-CoV-2疫苗对冷链容量与免疫工作负荷的潜在影响
该模拟研究基于WHO非洲区域国家的免疫、人口、医护人员、冷链容量及获批SARS-CoV-2疫苗特征数据,评估针对风险人群的四个月接种活动对月度疫苗剂次、每接种员剂次和冷链体积的影响。结果显示针对≥65岁、慢性病患者和医护人员的接种分别使月度总剂次增加27.0%、91.7%和1.1%,每接种员月度剂次相应增加29.3%、99.6%和1.2%。常规免疫疫苗体积已超至少75%国家国家级储存容量,但至少75%国家次国家级储存容量足以支持SARS-CoV-2疫苗。
要点
- 针对慢性病患者的SARS-CoV-2接种使月度总剂次增加91.7%,每接种员剂次增加99.6%。
- 针对≥65岁人群接种使月度总剂次增加27.0%,每接种员剂次增加29.3%。
- 至少75%国家次国家级冷链容量足以支持SARS-CoV-2疫苗,但国家级储存已近极限。
核心结论
- 在WHO非洲区域,SARS-CoV-2接种活动将较常规免疫基线大幅增加每接种员剂次和冷链容量需求。
- 大流行接种活动将增加已处极限的国家级储存需求,但次国家级存在足够容量。
- 亟需立即关注加强免疫系统以支持大流行应对。
研究设计与样本
- 模拟WHO非洲区域某国的研究,使用区域特异性免疫、人口、医护人员、冷链容量(国家和次国家级四分位值)及获批SARS-CoV-2疫苗特征数据。
- 计算针对风险人群的四个月SARS-CoV-2接种活动较常规免疫基线的月度疫苗剂次、每接种员剂次和冷链体积增量。
主要发现
- 针对≥65岁、慢性病患者和医护人员的接种使月度总剂次分别增加27.0%、91.7%和1.1%。
- 假设调整缺勤和提供免疫服务比例后的护士密度中位数,每接种员月度总剂次分别增加29.3%、99.6%和1.2%。
- 应用非洲区域国家疫苗储存容量四分位值,常规免疫疫苗体积超过至少75%国家的国家级储存容量。
- 至少75%国家的次国家级储存容量足以支持SARS-CoV-2疫苗。
临床怎么用
- 规划SARS-CoV-2接种活动时需评估每接种员工作负荷增量,针对慢性病患者和≥65岁人群需大幅增加接种人力。
- 应优先利用次国家级冷链容量,并加强国家级储存能力以应对大流行接种需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: SARS-CoV-2 vaccines will be deployed to countries with limited immunization systems. METHODS: We assessed the effect of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in a simulated WHO African Region country using region-specific data on immunization, population, healthcare workers (HCWs), cold storage capacity (quartile values for national and subnational levels), and characteristics of an approved SARS-CoV-2 vaccine. We calculated monthly increases in vaccine doses, doses per vaccinator, and cold storage volumes for four-month SARS-CoV-2 vaccination campaigns targeting risk groups compared to routine immunization baselines. RESULTS: Administering SARS-CoV-2 vaccines to risk groups would increase total monthly doses by 27.0% for ≥ 65 years, 91.7% for chronic diseases patients, and 1.1% for HCWs. Assuming median nurse density estimates adjusted for absenteeism and proportion providing immunization services, SARS-CoV-2 vaccination campaigns would increase total monthly doses per vaccinator by 29.3% for ≥ 65 years, 99.6% for chronic diseases patients, and 1.2% for HCWs. When we applied quartiles of actual African Region country vaccine storage capacity, routine immunization vaccine volumes exceeded national-level storage capacity for at least 75% of countries, but subnational levels had sufficient storage capacity for SARS-CoV-2 vaccines for at least 75% of countries. CONCLUSIONS: In the WHO African Region, SARS-CoV-2 vaccination campaigns would substantially increase doses per vaccinator and cold storage capacity requirements over routine immunization baselines. Pandemic vaccination campaigns would increase storage requirements of national-level stores already at their limits, but sufficient capacity exists at subnational levels. Immediate attention to strengthening immunization systems is essential to support pandemic responses.
引用
- Ortiz JR, Robertson J, Hsu JS, et al. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region. Vaccine. 2021. PMID: 33744049. doi:10.1016/j.vaccine.2021.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。